Hypnosis for Symptom Management in Elective Orthopedic Surgery

August 23, 2021 updated by: Jessie Kittle, Stanford University

A Randomized Study Using Hypnosis for Symptom Management in Elective Orthopedic Surgery

The purpose of the study is to determine if teaching self-hypnosis techniques to patients prior to knee replacement surgery will decrease their pain medication requirements, pain medication side-effects, length of stay in the hospital, readmission rates, pain, anxiety, physical function, satisfaction scores, and cost of admission.

Study Overview

Detailed Description

Patients will be recruited by through orthopedic surgery clinics or contacted by after pre-screening via chart review and given an information brochure. If they are interested in the trial will be emailed or given a paper copy of the consent form and scheduled for a single additional visit in the Integrative Medicine Center at Hoover Pavilion approximately 1 week before surgery. At the single study visit, participants would be consented, then a mini-mental state test would be performed to determine if participants are eligible by a score of 25 or above. If eligible, participants would be asked to fill out surveys relating to demographics, attitudes and experience with hypnosis, and detailed pain medication usage. Then, participants would be randomized to hypnosis vs. no hypnosis. The hypnosis group will undergo a Hypnotic Induction Profile to score hypnotizability, then be lead through a hypnosis induction and read a perioperative symptom management script, then re-alerted from hypnosis. Patients in this group would then be asked to listen to the same hypnosis script on a telephone recording twice per day until after the surgery when participants feel they don't need it anymore.

The control group will fill out the surveys and the study visit will end. Participants will be asked not to use any hypnosis until the trial period is over. Data regarding pain, activity, and satisfaction is already collected by email survey or by Ipad in orthopedic clinic at or before the pre-op visit, and 3 months post-op.

Patients in the knee study will be asked to fill out the same surveys around the two week and six week post-op orthopedic clinic visits as well. One additional survey will be added at the 2 week post-op visit to reassess attitudes and experience with hypnosis, and detailed pain medication usage. Those participants who do not fill out the survey will be called and/or emailed to remind them to fill it out.

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Palo Alto, California, United States, 94305
        • Stanford University/Stanford Healthcare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • At least 18 years old.
  • scheduled for a primary, unilateral, total knee replacement surgery within the study period
  • able to commit to a single study clinic visit at least one week prior to their scheduled surgery and use of phone recordings
  • able to read and understand English
  • Score at least 25 on mini-mental state exam

Exclusion Criteria:

  • severe psychiatric or structural brain disease (ie. psychosis, stroke with functional impairment, dementia)
  • current use of hypnosis/self-hypnosis
  • enrolled in other clinical trials related to pain management or length of stay
  • hearing impairment that would impede ability to listen to a phone recording

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hypnosis Group
Participants will undergo a brief hypnotic assessment, a single hypnosis session with an MD trained in hypnosis, and be given a phone number to listen to a guided self-hypnosis recording for 1 week pre-op until 2 weeks post-op.
Hypnotic induction, relaxation, and guided imagery specific to perioperative symptoms will be administered.
No Intervention: Usual care
These patients will be enrolled in the study and usual care will be provided.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Narcotic use
Time Frame: Index hospitalization for total knee replacement, average 2-3 days
Total narcotic use during the hospital stay will be calculated in "morphine equivalents"
Index hospitalization for total knee replacement, average 2-3 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Narcotic prescriptions
Time Frame: 1 month before, and 3 months and 1 year after joint replacement
Total narcotics prescribed in the outpatient setting
1 month before, and 3 months and 1 year after joint replacement
Narcotic-associated side effects
Time Frame: Index hospitalization for total knee replacement, average 2-3 days
Incidence of delirium, constipation, urinary retention, respiratory depression
Index hospitalization for total knee replacement, average 2-3 days
UCLA activity scores
Time Frame: At the pre-op visit with the surgeon and 2, 6 and 12 weeks post-op
Classifies the activity level of joint replacement patients
At the pre-op visit with the surgeon and 2, 6 and 12 weeks post-op
KOOS Jr Survey
Time Frame: At the pre-op visit with the surgeon and 2, 6 and 12 weeks post-op
Knee injury and osteoarthritis outcome score
At the pre-op visit with the surgeon and 2, 6 and 12 weeks post-op
VR-12 Survey
Time Frame: At the pre-op visit with the surgeon and 2, 6 and 12 weeks post-op
Measures health-related quality of life
At the pre-op visit with the surgeon and 2, 6 and 12 weeks post-op
Knee Society Score
Time Frame: At the pre-op visit with the surgeon and 12 weeks post-op
Prosthesis function and patients' functional abilities after total knee arthroplasty (TKA)
At the pre-op visit with the surgeon and 12 weeks post-op
Number of days hospitalized
Time Frame: Reported once , after patient is discharged (1 day)
Total number of days hospitalized for total knee replacement surgery
Reported once , after patient is discharged (1 day)
Satisfaction with hypnosis survey
Time Frame: Pre-op and 2 weeks post-op
Attitudes and expectations regarding hypnosis
Pre-op and 2 weeks post-op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 20, 2017

Primary Completion (Actual)

August 30, 2019

Study Completion (Actual)

August 30, 2020

Study Registration Dates

First Submitted

June 23, 2017

First Submitted That Met QC Criteria

October 11, 2017

First Posted (Actual)

October 12, 2017

Study Record Updates

Last Update Posted (Actual)

August 25, 2021

Last Update Submitted That Met QC Criteria

August 23, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Clinical Trials on Hypnosis

3
Subscribe